These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Efficacy and safety of tacrolimus ointment in pediatric Patients with moderate to severe atopic dermatitis. Singalavanija S; Noppakun N; Limpongsanuruk W; Wisuthsarewong W; Aunhachoke K; Chunharas A; Wananukul S; Akaraphanth R J Med Assoc Thai; 2006 Nov; 89(11):1915-22. PubMed ID: 17205874 [TBL] [Abstract][Full Text] [Related]
24. Treatment of localized lesions of canine atopic dermatitis with tacrolimus ointment: a blinded randomized controlled trial. Bensignor E; Olivry T Vet Dermatol; 2005 Feb; 16(1):52-60. PubMed ID: 15725106 [TBL] [Abstract][Full Text] [Related]
25. Comparison of effects of tacrolimus ointment and mometasone furoate cream on the epidermal barrier of patients with atopic dermatitis. Dähnhardt-Pfeiffer S; Dähnhardt D; Buchner M; Walter K; Proksch E; Fölster-Holst R J Dtsch Dermatol Ges; 2013 May; 11(5):437-43. PubMed ID: 23551950 [TBL] [Abstract][Full Text] [Related]
26. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis. Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179 [TBL] [Abstract][Full Text] [Related]
27. Investigation on the clinical efficacy and safety of 0.1% tacrolimus ointment (Protopic) in canine atopic dermatitis: a randomized, double-blinded, placebo-controlled, cross-over study. Marsella R; Nicklin CF; Saglio S; Lopez J Vet Dermatol; 2004 Oct; 15(5):294-303. PubMed ID: 15500481 [TBL] [Abstract][Full Text] [Related]
28. Tacrolimus ointment in the treatment of eyelid dermatitis. Freeman AK; Serle J; VanVeldhuisen P; Lind L; Clarke J; Singer G; Lebwohl M Cutis; 2004 Apr; 73(4):267-71. PubMed ID: 15134327 [TBL] [Abstract][Full Text] [Related]
29. Tacrolimus ointment 0.03% shows efficacy and safety in pediatric and adult patients with mild to moderate atopic dermatitis. Chapman MS; Schachner LA; Breneman D; Boguniewicz M; Gold MH; Shull T; Linowski GJ; Jaracz E; J Am Acad Dermatol; 2005 Aug; 53(2 Suppl 2):S177-85. PubMed ID: 16021173 [TBL] [Abstract][Full Text] [Related]
31. A bilateral comparison study of pimecrolimus cream 1% and a topical medical device cream in the treatment of patients with atopic dermatitis. Emer JJ; Frankel A; Sohn A; Lebwohl M J Drugs Dermatol; 2011 Jul; 10(7):735-43. PubMed ID: 21720655 [TBL] [Abstract][Full Text] [Related]
32. Long-term treatment with 0.1% tacrolimus ointment in adults with atopic dermatitis: results of a two-year, multicentre, non-comparative study. Reitamo S; Ortonne JP; Sand C; Bos J; Cambazard F; Bieber T; Grønhøj-Larsen C; Rustin M; Fölster-Holst R; Schuttelaar M; Acta Derm Venereol; 2007; 87(5):406-12. PubMed ID: 17721647 [TBL] [Abstract][Full Text] [Related]
33. 0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial. Reitamo S; Harper J; Bos JD; Cambazard F; Bruijnzeel-Koomen C; Valk P; Smith C; Moss C; Dobozy A; Palatsi R; Br J Dermatol; 2004 Mar; 150(3):554-62. PubMed ID: 15030341 [TBL] [Abstract][Full Text] [Related]
34. Tacrolimus ointment vs steroid ointment for eyelid dermatitis in patients with atopic keratoconjunctivitis. Nivenius E; van der Ploeg I; Jung K; Chryssanthou E; van Hage M; Montan PG Eye (Lond); 2007 Jul; 21(7):968-75. PubMed ID: 16680103 [TBL] [Abstract][Full Text] [Related]
35. Safe treatment of head/neck AD with tacrolimus ointment. Kang S; Paller A; Soter N; Satoi Y; Rico MJ; Hanifin JM J Dermatolog Treat; 2003 Jun; 14(2):86-94. PubMed ID: 12775315 [TBL] [Abstract][Full Text] [Related]
36. Tacrolimus ointment is safe and effective in the treatment of atopic dermatitis: results in 8000 patients. Koo JY; Fleischer AB; Abramovits W; Pariser DM; McCall CO; Horn TD; Gottlieb AB; Jaracz E; Rico MJ J Am Acad Dermatol; 2005 Aug; 53(2 Suppl 2):S195-205. PubMed ID: 16021175 [TBL] [Abstract][Full Text] [Related]
37. Topical [symbol: see text] tacrolimus--a role in atopic dermatitis? Drug Ther Bull; 2002 Oct; 40(10):73-5. PubMed ID: 12434738 [TBL] [Abstract][Full Text] [Related]
38. Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group. Reitamo S; Wollenberg A; Schöpf E; Perrot JL; Marks R; Ruzicka T; Christophers E; Kapp A; Lahfa M; Rubins A; Jablonska S; Rustin M Arch Dermatol; 2000 Aug; 136(8):999-1006. PubMed ID: 10926735 [TBL] [Abstract][Full Text] [Related]
39. Proactive disease management with 0.03% tacrolimus ointment for children with atopic dermatitis: results of a randomized, multicentre, comparative study. Thaçi D; Reitamo S; Gonzalez Ensenat MA; Moss C; Boccaletti V; Cainelli T; van der Valk P; Buckova H; Sebastian M; Schuttelaar ML; Ruzicka T; Br J Dermatol; 2008 Dec; 159(6):1348-56. PubMed ID: 18782319 [TBL] [Abstract][Full Text] [Related]
40. Tacrolimus ointment is more effective than pimecrolimus cream with a similar safety profile in the treatment of atopic dermatitis: results from 3 randomized, comparative studies. Paller AS; Lebwohl M; Fleischer AB; Antaya R; Langley RG; Kirsner RS; Blum RR; Rico MJ; Jaracz E; Crowe A; Linowski GJ; J Am Acad Dermatol; 2005 May; 52(5):810-22. PubMed ID: 15858471 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]